• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TM4SF1 通过 PPARγ-SIRT1 反馈回路调节人膀胱癌细胞的细胞凋亡、细胞周期和 ROS 代谢。

TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARγ-SIRT1 feedback loop in human bladder cancer cells.

机构信息

Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China; Department of Urology, The Fifth Hospital of Wuhan, Wuhan, China.

出版信息

Cancer Lett. 2018 Feb 1;414:278-293. doi: 10.1016/j.canlet.2017.11.015. Epub 2017 Nov 24.

DOI:10.1016/j.canlet.2017.11.015
PMID:29175458
Abstract

Transmembrane-4-L-Six-Family-1 (TM4SF1) is a member of the L6 family and functions as a signal transducer to regulate cell development, growth and motility. Here we show that TM4SF1 is strongly upregulated in human muscle invasive bladder cancer (MIBC) tissues, corroborating the bioinformatical results of transcriptome analysis. Moreover, tissue microarray (TMA) shows significant correlations (p < 0.05) between high expression of TM4SF1 and T stage, TNM stage, lymph node metastasis status and survival rate of MIBC patients, indicating a positive association between TM4SF1 expression and poorer prognosis. Furthermore, in vitro and in vivo studies indicate that the proliferation of human bladder cancer (BCa) cells is significantly suppressed by knockdown of TM4SF1 (p < 0.05). Functionally, the reduction of TM4SF1 could induce cell cycle arrest and apoptosis possibly via the upregulation of reactive oxygen species (ROS) in BCa cells. In addition, these observations could be recovered by treatment with GW9662 (antagonist of PPARγ) and resveratrol (activator of SIRT1). Taken together, our results suggest that high expression of TM4SF1 predicts poor prognosis of MIBC.

摘要

跨膜 4 结构域家族 1(TM4SF1)是 L6 家族的成员,作为信号转导物调节细胞发育、生长和运动。在这里,我们表明 TM4SF1 在人类肌肉浸润性膀胱癌(MIBC)组织中强烈上调,与转录组分析的生物信息学结果一致。此外,组织微阵列(TMA)显示 TM4SF1 高表达与 T 分期、TNM 分期、淋巴结转移状态和 MIBC 患者生存率之间存在显著相关性(p<0.05),表明 TM4SF1 表达与预后不良之间存在正相关。此外,体外和体内研究表明,TM4SF1 敲低显著抑制人膀胱癌(BCa)细胞的增殖(p<0.05)。功能上,TM4SF1 的减少可能通过上调 BCa 细胞中的活性氧(ROS)诱导细胞周期停滞和细胞凋亡。此外,这些观察结果可以通过用 GW9662(PPARγ 拮抗剂)和白藜芦醇(SIRT1 激活剂)处理来恢复。总之,我们的研究结果表明,TM4SF1 的高表达预示着 MIBC 的预后不良。

相似文献

1
TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARγ-SIRT1 feedback loop in human bladder cancer cells.TM4SF1 通过 PPARγ-SIRT1 反馈回路调节人膀胱癌细胞的细胞凋亡、细胞周期和 ROS 代谢。
Cancer Lett. 2018 Feb 1;414:278-293. doi: 10.1016/j.canlet.2017.11.015. Epub 2017 Nov 24.
2
PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells.过氧化物酶体增殖物激活受体 γ 抑制可调控膀胱癌细胞的细胞周期、增殖和迁移。
J Cell Mol Med. 2019 May;23(5):3724-3736. doi: 10.1111/jcmm.14280. Epub 2019 Mar 25.
3
Knockdown of Suppresses Bladder Cancer Cell Proliferation and Migration and Induces Cell Cycle Arrest and Antioxidant Response through FOXO3a-Mediated Pathways.通过 FOXO3a 介导的途径敲低 Suppresses 可抑制膀胱癌细胞增殖和迁移,并诱导细胞周期停滞和抗氧化反应。
Biomed Res Int. 2017;2017:3781904. doi: 10.1155/2017/3781904. Epub 2017 Sep 25.
4
TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo.TM4SF1在体外和体内调节胰腺癌的迁移和侵袭。
Cell Physiol Biochem. 2016;39(2):740-50. doi: 10.1159/000445664. Epub 2016 Jul 27.
5
Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT.miR-141缺失和TM4SF1表达上调与胰腺癌预后不良相关:miR-141和TM4SF1通过AKT对上皮-间质转化和血管生成的调控
Cancer Biol Ther. 2020 Apr 2;21(4):354-363. doi: 10.1080/15384047.2019.1702401. Epub 2020 Jan 7.
6
Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.TRPM7表达降低通过ERK1/2信号通路抑制膀胱癌细胞活性并诱导其凋亡。
Oncotarget. 2016 Nov 8;7(45):72941-72960. doi: 10.18632/oncotarget.12146.
7
Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.TM4SF1 作为胃癌肿瘤抑制基因的临床意义。
Cancer Med. 2018 Jun;7(6):2592-2600. doi: 10.1002/cam4.1494. Epub 2018 Apr 17.
8
TM4SF1 promotes glioma malignancy through multiple mechanisms.TM4SF1 通过多种机制促进神经胶质瘤恶性转化。
Neoplasma. 2022 Jul;69(4):859-867. doi: 10.4149/neo_2022_211009N1427. Epub 2022 May 9.
9
miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1.miR-30 家族减少通过靶向癌基因 TM4SF1 维持 NSCLC 起始细胞的自我更新并促进肿瘤发生。
Mol Ther. 2018 Dec 5;26(12):2751-2765. doi: 10.1016/j.ymthe.2018.09.006. Epub 2018 Sep 13.
10
TM4SF1 facilitates non-small cell lung cancer progression through regulating YAP-TEAD pathway.TM4SF1 通过调控 YAP-TEAD 通路促进非小细胞肺癌进展。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):1829-1840. doi: 10.26355/eurrev_202002_20361.

引用本文的文献

1
Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expression.膀胱癌变体具有侵袭性特征,包括CA125阳性细胞状态和可靶向的TM4SF1表达。
Nat Commun. 2025 Jun 17;16(1):5312. doi: 10.1038/s41467-025-59888-8.
2
Current research of the Notch pathway in hepatocellular carcinoma.Notch信号通路在肝细胞癌中的当前研究
Eur J Med Res. 2025 May 20;30(1):402. doi: 10.1186/s40001-025-02626-z.
3
LMNA R482L mutation causes impairments in C2C12 myoblasts subpopulations, alterations in metabolic reprogramming during differentiation, and oxidative stress.
LMNA基因R482L突变导致C2C12成肌细胞亚群受损、分化过程中代谢重编程改变以及氧化应激。
Sci Rep. 2025 Feb 13;15(1):5358. doi: 10.1038/s41598-025-88219-6.
4
Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells.肿瘤细胞中mTOR介导的顺铂反应的分子机制。
Heliyon. 2024 Dec 25;11(1):e41483. doi: 10.1016/j.heliyon.2024.e41483. eCollection 2025 Jan 15.
5
USP20 mediates malignant phenotypic changes in bladder cancer through direct interactions with YAP1.USP20通过与YAP1直接相互作用介导膀胱癌的恶性表型变化。
Neoplasia. 2025 Feb;60:101102. doi: 10.1016/j.neo.2024.101102. Epub 2024 Dec 13.
6
Mevalonate pathway inhibition reduces bladder cancer metastasis by modulating RhoB protein stability and integrin β1 localization.甲羟戊酸途径抑制通过调节 RhoB 蛋白稳定性和整合素 β1 定位减少膀胱癌转移。
Commun Biol. 2024 Nov 9;7(1):1476. doi: 10.1038/s42003-024-07067-8.
7
Identification and Validation of Prognostic Model for Tumor Microenvironment-Associated Genes in Bladder Cancer Based on Single-Cell RNA Sequencing Data Sets.基于单细胞 RNA 测序数据集的膀胱癌肿瘤微环境相关基因预后模型的鉴定和验证。
JCO Precis Oncol. 2024 Aug;8:e2300661. doi: 10.1200/PO.23.00661.
8
Advancing bladder cancer management: development of a prognostic model and personalized therapy.推进膀胱癌管理:预后模型的建立与个体化治疗。
Front Immunol. 2024 Jul 22;15:1430792. doi: 10.3389/fimmu.2024.1430792. eCollection 2024.
9
Integrative Single Cell Atlas Revealed Intratumoral Heterogeneity Generation from an Adaptive Epigenetic Cell State in Human Bladder Urothelial Carcinoma.整合单细胞图谱揭示了人类膀胱癌中适应性表观遗传细胞状态引起的肿瘤内异质性产生。
Adv Sci (Weinh). 2024 Jun;11(24):e2308438. doi: 10.1002/advs.202308438. Epub 2024 Apr 6.
10
Role of the NF-kB signalling pathway in heterotopic ossification: biological and therapeutic significance.NF-κB 信号通路在异位骨化中的作用:生物学和治疗意义。
Cell Commun Signal. 2024 Mar 4;22(1):159. doi: 10.1186/s12964-024-01533-w.